Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1420-1422

  Rivière, Yves ^a   Buseyne, Florence ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

GTL; HIV 1; Infants

Indexed keywords

CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; LYMPHOCYTE FUNCTION; MOLECULAR RECOGNITION; PERINATAL INFECTION; PRIORITY JOURNAL;

ADULT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032147016     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00102-9     Document Type: Conference Paper

References (21)

1. 1 Walker, C.M., Moody, D.J., Stites, P. and Levy, J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234, 1563-1567
2. 2 Buseyne, F., Février, S., Garcia, S., Gougeon, M.L. and Rivière, Y. Dual functions of a Human Immunodeficiency Virus (HIV) specific cytotoxic T-lymphocytes (CTL) clone: inhibition of HIV replication by non-cytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology 1996, 225, 248-253
3. 3 Wilson, C.B., Lewis, D.B. and Penix, L.A. The physiologic immunodeficiency of immaturity. In: Immunologic Disorders in Infants and Children, 4th edn, (Ed. Stiehm, E.R.). Saunders, Philadelphia, 1996, pp. 253-295
4. 4 Koup, R. A. and Wilson, C. B. Clinical immunology of HIV-infected children. In: Pediatric AIDS, 2nd edition (Eds Pizzo, P.A. and Wilfert, C.M.). Williams and Wilkins, Baltimore, 1994, pp. 129-157
5. 5 Isaacs, D., Dangham, C.R.M. and McMichael, A.J. Cell-mediated cytotoxic response to respiratory syncitial virus in infants with bronchiolitis. Lancet 1987, 769-771
6. 6 Chiba, Y., Higashidate, Y., Suga, K., Honjo, K., Tsutsumi, H. and Ogra, P.L. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally-acquired infection. J. Med. Virol. 1989, 28, 133-139
7. 7 Mbawuike, I.N., Piedra, P.A., Cate, T.R. and Couch, R.B. Cytotoxic T lymphocytes responses of infants after natural influenza infection or immunization with live-cold recombinant or inactivated influenza A virus vaccine. J. Med. Virol. 1996, 50, 105-111
8. 8 Luzuriaga, K., Koup, R.A., Pikora, C.A., Bretter, D.B. and Sullivan, J.L. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J. Pediatr. 1991, 119, 230-236
9. 9 Buseyne, F., Blanche, S., Schmitt, D., Griscelli, C. and Rivière, Y. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J. Immunol. 1993, 150, 3569-3581
10. 10 McFarland, E.J., Harding, P.A., Luckey, D., Conway, B., Young, R.K. and Kuritzkes, D.R. High frequency of gag-and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J. Infect. Dis. 1994, 170, 766-774
11. 11 Johnson, R.P. and Walker, B.D. Cytotoxic T lymphocytes in Human Immunodeficiency Virus infection: responses to structural proteins. Curr. Top. Microbiol. Immunol. 1994, 189, 35-63
12. 12 Rivière, Y., Robertson, M.N. and Buseyne, F. Cytotoxic T lymphocytes in Human Immunodeficiency Virus infection: regulator genes. Curr. Top. Microbiol. Immunol. 1994, 189, 65-74
13. 13 Rivière, Y., Tanneau, F. and Regnault, A. et al. Human immunodeficiency virus specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing env and gag. J. Virol. 1989, 63, 2270-2279
14. 14 McChesney, M., Tanneau, F., Regnault, A., Sansonetti, P., Montagnier, L. and Rivière, Y. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env aminoterminal signal sequence. Europ. J. Immunol. 1990, 20, 215-219
15. 15 Luzuriaga, K., Holmes, D., Hereema, A., Wong, J., Panicali, D.L. and Sullivan, J.L. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 1995, 154, 433-443
16. 16 Greenough, T.C., Brettler, D.B., Somasundaran, M., Panicali, D.L. and Sullivan, J.L. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), viral load, and CD4+ T cell loss: evidence supporting a protective role for CTL in vivo. J. Infect. Dis. 1997, 176, 118-125
17. 17 Klein, M.R., Van Baalen, C.A. and Holwerda, A.M. et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection; a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 1995, 181, 1365-1372
18. 18 Rivière, Y., McChesney, M.B. and Porrot, F. et al. Gag-specific cytotoxic responses to HIV-1 are associated with a decreased risk of progression to ARC or AIDS. AIDS Res. Hum. Retroviruses 1995, 11, 903-907
19. 19 Borrow, P., Lewicki, H., Hahn, B., Shaw, G.M. and Oldstone, M.B.A. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus infection. J. Virol. 1994, 68, 6103-6110
20. 20 Koup, R., Safrit, R.A. and Cao, J.T. et al. Temporal association of cellular immune responses with the initial control of viremia in primary immunodeficiency virus type 1 syndrome. J. Virol. 1994, 68, 4650-4655
21. 21 Blanche, S., Tardieu, M. and Duliège, A.M. et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. A.J.D.C. 1990, 144, 1210-1215